15-05-2025
Kepler Capital Reaffirms Their Buy Rating on Eckert & Ziegler Strahlen und Medizintechnik (0NZY)
In a report released on May 13, Nicolas Pauillac from Kepler Capital maintained a Buy rating on Eckert & Ziegler Strahlen und Medizintechnik (0NZY – Research Report), with a price target of €60.30. The company's shares closed last Friday at €39.74.
Confident Investing Starts Here:
Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Pauillac is ranked #1649 out of 9519 analysts.
Currently, the analyst consensus on Eckert & Ziegler Strahlen und Medizintechnik is a Moderate Buy with an average price target of €63.15.
